These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37781899)

  • 61. An α-helix mimetic oligopyridylamide, ADH-31, modulates Aβ
    Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2020 Dec; 22(48):28055-28073. PubMed ID: 33289734
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Conformational stability of fibrillar amyloid-beta oligomers via protofilament pair formation - a systematic computational study.
    Kahler A; Sticht H; Horn AH
    PLoS One; 2013; 8(7):e70521. PubMed ID: 23936224
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.
    Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D
    ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Destabilization of the Alzheimer's amyloid-β peptide by a proline-rich β-sheet breaker peptide: a molecular dynamics simulation study.
    Kanchi PK; Dasmahapatra AK
    J Mol Model; 2021 Nov; 27(12):356. PubMed ID: 34796404
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular insights into Aβ
    Saini RK; Shuaib S; Goyal B
    J Mol Recognit; 2017 Dec; 30(12):. PubMed ID: 28850770
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer's disease.
    Ghosh P; Kumar A; Datta B; Rangachari V
    BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S24. PubMed ID: 20946608
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Green Tea Extracts EGCG and EGC Display Distinct Mechanisms in Disrupting Aβ
    Zhan C; Chen Y; Tang Y; Wei G
    ACS Chem Neurosci; 2020 Jun; 11(12):1841-1851. PubMed ID: 32441920
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identifying the key residues instrumental in imparting stability to amyloid beta protofibrils - a comparative study using MD simulations of 17-42 residues.
    Dutta MS; Basu S
    J Biomol Struct Dyn; 2021 Feb; 39(2):431-456. PubMed ID: 31900057
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Curcumin Binding to Beta Amyloid: A Computational Study.
    Rao PP; Mohamed T; Teckwani K; Tin G
    Chem Biol Drug Des; 2015 Oct; 86(4):813-20. PubMed ID: 25776887
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cyclization Scaffolding for Improved Vaccine Immunogen Stability: Application to Tau Protein in Alzheimer's Disease.
    Hsueh SCC; Nijland M; Aina A; Plotkin SS
    J Chem Inf Model; 2024 Mar; 64(6):2035-2044. PubMed ID: 38427576
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Green tea extract EGCG plays a dual role in Aβ
    Dong X; Tang Y; Zhan C; Wei G
    Chem Phys Lipids; 2021 Jan; 234():105024. PubMed ID: 33278382
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of two VQIXXK motifs for tau fibrillization in vitro.
    Li W; Lee VM
    Biochemistry; 2006 Dec; 45(51):15692-701. PubMed ID: 17176091
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modeling the Alzheimer Abeta17-42 fibril architecture: tight intermolecular sheet-sheet association and intramolecular hydrated cavities.
    Zheng J; Jang H; Ma B; Tsai CJ; Nussinov R
    Biophys J; 2007 Nov; 93(9):3046-57. PubMed ID: 17675353
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Triazole-Peptide Conjugate as a Modulator of Aβ-Aggregation, Metal-Mediated Aβ-Aggregation, and Cytotoxicity.
    Mann S; Kaur A; Kaur A; Priyadarshi N; Goyal B; Singhal NK; Goyal D
    ACS Chem Neurosci; 2023 May; 14(9):1631-1645. PubMed ID: 37040092
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells.
    Panda C; Voelz C; Habib P; Mevissen C; Pufe T; Beyer C; Gupta S; Slowik A
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209408
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Mechanism for the Inhibition of Tau Neurotoxicity: Studies with Artificial Membranes, Isolated Mitochondria, and Intact Cells.
    Naveh Tassa S; Ben Zichri S; Lacham-Hartman S; Oren O; Slobodnik Z; Eremenko E; Toiber D; Jelinek R; Papo N
    ACS Chem Neurosci; 2021 May; 12(9):1563-1577. PubMed ID: 33904703
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In silico investigation and targeting of amyloid β oligomers of different size.
    Autiero I; Saviano M; Langella E
    Mol Biosyst; 2013 Aug; 9(8):2118-24. PubMed ID: 23708585
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular Dynamics Simulations of the Tau Amyloid Fibril Core Dimer at the Surface of a Lipid Bilayer Model: I. In Alzheimer's Disease.
    Nguyen PH; Derreumaux P
    J Phys Chem B; 2022 Jul; 126(26):4849-4856. PubMed ID: 35759677
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Study on the inter- and intra-peptide salt-bridge mechanism of Aβ23-28 oligomer interaction with small molecules: QM/MM method.
    Boopathi S; Kolandaivel P
    Mol Biosyst; 2015 Jul; 11(7):2031-41. PubMed ID: 25973904
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β
    Shuaib S; Goyal B
    J Biomol Struct Dyn; 2018 Feb; 36(3):663-678. PubMed ID: 28162045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.